Arkansas Administrative Code › Agency 007 - ARKANSAS DEPARTMENT OF HEALTH › Division 35 - Center for Health Protection › Rule 007.35.23-007 - Controlled Substances List

Current through Register Vol. 49, No. 6, June, 2024
ARTICLE
			 II
SCHEDULE I
(a) Schedule I shall consist of the drugs and
			 other substances, by whatever official name, common or usual name, chemical
			 name, or brand name designated, listed in this section. Each drug or substance
			 has been assigned the DEA Controlled Substances Code Number set forth opposite
			 it.
(b)
Opiates: (Narcotic
			 Drugs)
Unless specifically excepted or unless listed in another
			 schedule, any of the following opiates, including their isomers, esters,
			 ethers, salts, and salts of isomers, esters, and ethers, whenever the existence
			 of such isomers, esters, ethers, salts is possible within the specific chemical
			 designation (for purposes of 3-methylthiofentanyl only, the term isomer
			 includes the optical and geometric isomers):
(1) Acetylmethadol
			 ----------------------------------------------------------------------------------------
			 9601*
(2) Allylprodine
			 --------------------------------------------------------------------------------------------
			 9602*
(3) Alphacetylmethadol
			 (except Levo-alphacetylmethadol (LAAM) --------------------------------
			 9603*
(4) Alphameprodine
			 ---------------------------------------------------------------------------------------
			 9604*
(5) Alphamethadol
			 ----------------------------------------------------------------------------------------
			 9605*
(6) Benzethidine
			 -------------------------------------------------------------------------------------------
			 9606*
(7) Betacetylmethadol
			 ------------------------------------------------------------------------------------
			 9607*
(8) Betameprodine
			 -----------------------------------------------------------------------------------------
			 9608*
(9) Betamethadol
			 ------------------------------------------------------------------------------------------
			 9609*
(10) Betaprodine
			 -----------------------------------------------------------------------------------------
			 9611*
(11) Dextromoramide
			 -----------------------------------------------------------------------------------
			 9613*
(12) Diampromide
			 ---------------------------------------------------------------------------------------
			 9615*
(13) Diethylthiambutene
			 --------------------------------------------------------------------------------
			 9616*
(14) Difenoxin
			 -------------------------------------------------------------------------------------------
			 9168*
(15) Dimenoxadol
			 ---------------------------------------------------------------------------------------
			 9617*
(16) Dimepheptanol
			 -------------------------------------------------------------------------------------
			 9618*
(17) Dimethylthiambutene
			 -----------------------------------------------------------------------------
			 9619*
(18) Dioxaphetyl butyrate
			 ------------------------------------------------------------------------------
			 9621*
(19) Dipipanone
			 -----------------------------------------------------------------------------------------
			 9622*
(20) Ethylmethylthiambutene
			 --------------------------------------------------------------------------
			 9623*
(21) Etoxeridine
			 -----------------------------------------------------------------------------------------
			 9625*
(22) Furethidine
			 ------------------------------------------------------------------------------------------
			 9626*
(23) Hydroxypethidine
			 ----------------------------------------------------------------------------------
			 9627*
(24) Ketobemidone
			 --------------------------------------------------------------------------------------
			 9628*
(25) Levomoramide
			 -------------------------------------------------------------------------------------
			 9629*
(26) Levophenacylmorphan
			 ----------------------------------------------------------------------------
			 9631*
(27) Morpheridine
			 ---------------------------------------------------------------------------------------
			 9632*
(28) MPPP [other name(s):
			 (1-methyl-4-phenyl-4-propionoxypiperidine)] ---------- 9661-(10-1985)
(29) Noracymethadol
			 -----------------------------------------------------------------------------------
			 9633*
(30) Norlevorphanol
			 ------------------------------------------------------------------------------------
			 9634*
(31) Normethadone
			 --------------------------------------------------------------------------------------
			 9635*
(32) Norpipanone
			 ----------------------------------------------------------------------------------------
			 9636*
(33) PEPAP [other name(s):
			 1-(2-phenylethyl)-4-phenyl-4 acetyloxypiper-idine] - 9663-(10-1985)
(34) Phenadoxone
			 ---------------------------------------------------------------------------------------
			 9637*
(35) Phenampromide
			 ------------------------------------------------------------------------------------
			 9638*
(36) Phenomorphan
			 -------------------------------------------------------------------------------------
			 9647*
(37) Phenoperidine
			 --------------------------------------------------------------------------------------
			 9641*
(38) Piritramide
			 ------------------------------------------------------------------------------------------
			 9642*
(39) Proheptazine
			 ----------------------------------------------------------------------------------------
			 9643*
(40) Properidine
			 -----------------------------------------------------------------------------------------
			 9644*
(41) Propiram
			 --------------------------------------------------------------------------------------------
			 9649*
(42) Racemoramide
			 -------------------------------------------------------------------------------------
			 9645*
(43) Tilidine
			 ------------------------------------------------------------------------------------
			 9750-(9-1981)
(44) Trimeperidine
			 --------------------------------------------------------------------------------------
			 9646*
(45) Acetyl norfentanyl
			 [other name(s): N-phenyl-N-4-piperidinyl-acetamide] ---------------
			 (4-2017)
(46) AH-7921 [other
			 name(s):
			 3,4-dichloro-
N
-[(1-dimethylamino)cyclohexylmethyl]benzamide]
			 -------------------------------------------- 9551-(4-2017)
(47) W-18 [other name(s):
			 1-(4-nitrophenylethyl)piperidylidene-2-(4-chlorophenyl)sulfonamide]
			 -------------------------------------------------------------------------
			 (4-2017)
(48) W-15 [other name(s):
			 1-phenylethylpiperidylidene-2-(4-chlorophenyl)Sulfonamide]
			 ------------------------------------------------------------------------
			 (4-2017)
(49) MT-45 [other name(s):
			 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine] ----------
			 9560-(4-2017)
(50) U-47700 [other
			 name(s): trans-3,4-dichloro-N-(2-(dimethylamino)cyclohexyl)-N-methylbenzamide]
			 ------------------------------------------------------------------------
			 9547-(4-2017)
(51) Fentanyl-related
			 substances, their isomers, esters, ethers, salts and salts of isomers, esters
			 and ethers. Fentanyl-related substance means any substance not otherwise
			 listed, and for which no exemption or approval is in effect under section 505
			 of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 355], that
			 is structurally related to fentanyl by one or more of the following
			 modifications: ------------ (4-2021)
(i)
			 Replacement of the phenyl portion of the phenethyl group by any monocycle,
			 whether or not further substituted in or on the monocycle;
(ii) Substitution in or on the phenethyl
			 group with alkyl, alkenyl, alkoxyl, hydroxyl, halo, haloalkyl, amino or nitro
			 groups;
(iii) Substitution in or on
			 the piperidine ring with alkyl, alkenyl, alkoxyl, ester, ether, hydroxyl, halo,
			 haloalkyl, amino or nitro groups;
(iv) Replacement of the aniline ring with any
			 aromatic monocycle whether or not further substituted in or on the aromatic
			 monocycle; or
(v) Replacement of
			 the N-propionyl group by another acyl group.
(vi) Fentanyl-related substances shall
			 include, but are not limited to:
(A)
			 Acetyl-alpha-methylfentanyl [other name(s):
			 (N-[1-[1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide)]
			 --------------------------------- 9815-(2-1986)
(B) Alpha-methylfentanyl [other name(s):
			 (N-[1-(alpha-methyl-beta-phenyl) ethyl-4-piperidyl] propronanilide;
			 1-(1-methyl-2-phenylethyl)-4(N-propanilido)piperidine)]
			 -----------------------------------------------------------
			 9814-(6-1982)
(C)
			 Alpha-methylthiofentanyl(N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide)
			 ------------------------------------------------------------
			 9832-(2-1986)
(D)
			 Beta-hydroxyfentanyl [other name(s):
			 (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide)]
			 -------------------------------------------- 9830-(2-1986)
(E) Beta-hydroxy-3-methylfentanyl [other
			 name(s):
			 N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropamamide]
			 ---------------- 9831-(2-1986)
(F)
			 3-Methylfentanyl [other name(s):
			 (N-[3-Methyl-1-(2-phenylethyl)-4-piperidyl]-N-Phenylpropanamide)]
			 --------------------------------------------- 9813-(10-1985)
(G) 3-methylthiofentanyl
			 (N-[(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide)
			 ---------------------------------------------------------------
			 9833-(2-1986)
(H)
			 Para-fluorofentanyl [other name(s):
			 (N-[4-fluorophenyl)-N-[1-(2-phenenthyl)-4-piperindinyl]propananmide]
			 ----------------------------------- 9812-(11-1986)
(I) Thiofentanyl
			 (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-propanamide
			 -----------------------------------------------------------------------------------
			 9835-(2-1986)
(J) Acetyl fentanyl
			 [other name(s): N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide]
			 --------------------------------------------------------------------
			 9821-(4-2017)
(K) Butyryl fentanyl
			 [other name(s): N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide]
			 -------------------------------------------------------------------
			 9822-(4-2017)
(L)
			 Beta-hydroxythiofentanyl [other name(s):
			 N-{1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl}-N-phenylpropionamide]
			 -------------------------------- 9836-(4-2017)
(M) Acetyl fentanyl 4-methylphenethyl analog
			 [other name(s):
			 N-{1-[2-(4-methylphenyl)ethyl]-4-piperidinyl}-N-phenyl-acetamide]
			 ------------------------ (4-2017)
(N) Valeryl fentanyl [other name(s):
			 N-phenyl-N[1-(2-phenylethyl)-4-piperidinyl]-pentanamide]
			 ----------------------------------------------------------
			 9840-(4-2017)
(O) Furanyl fentanyl
			 [other name(s):
			 N-(1-(2-phenylethyl)-4-piperidinyl)-N-phenylfuran-2-carboxamide]
			 ------------------------------------------------------- 9834-(4-2017)
(P) Isobutyryl fentanyl [other name(s):
			 2-methyl-N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-propanamide]
			 ---------------------------------------- 9827-(4-2017)
(Q) Ocfentanil [other name(s):
			 N-(2-fluorophenyl)-2-methoxy-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide]
			 -------------------------------------------- 9838-(4-2017)
(R) 4-methoxy butyryl fentanyl [other
			 name(s): N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide]
			 ---------------------------------------------------- (4-2017)
(S) Para-fluorobutyryl fentanyl [other
			 name(s): N-(4-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]-butanamide]
			 ----------------------------------------- 9823-(4-2017)
(T) Acryl fentanyl [other name(s):
			 N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide]
			 ------------------------------------------------------------------
			 9811-(6-2020)
(U)
			 4-Fluoroisobutyryl fentanyl [other name(s):
			 N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide]
			 ------------------------------------------ 9824-(6-2020)
(V) Tetrahydrofuranyl fentanyl [other
			 name(s): N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide]
			 --------------------------------------- 9843-(6-2020)
(W) Cyclopropyl fentanyl [other name(s):
			 N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide]
			 --------------------------------------------- 9845-(4-2021)
(X) Methoxyacetyl fentanyl [other name(s):
			 2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide]
			 --------------------------------- 9825-(4-2021)
(Y) Ortho-fluorofentanyl [other name(s):
			 N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide]
			 ----------------------------------------- 9816-(4-2021)
(Z) Crotonyl fentanyl [other name(s):
			 (E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide]
			 -------------------------------------------------------------
			 9844-(5-2022)
(AA) Cyclopentyl
			 fentanyl [other name(s):
			 N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide]
			 --------------------------------------------- 9847-(5-2022)
(BB) Para-chloroisobutyryl fentanyl [other
			 name(s): N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide]
			 ---------------------------------- 9826-(5-2022)
(CC) Para-methoxybutyryl fentanyl [other
			 name(s): N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide]
			 ----------------- 9837-(5-2022)
(DD) Beta-methyl fentanyl [other name(s):
			 N-phenyl-N-(1-(2-phenylpropyl) piperidin-4-yl)propionamide]
			 ----------------------------------- 9856-(5-2022)
(EE) Beta'-phenyl fentanyl [other name:
			 N-(1-phenethylpiperidin-4-yl)-N,3-diphenylpropanamide]
			 ------------------------------------------------------- 9842-(5-2022)
(FF) 2'-Fluoro ortho-fluorofentanyl [other
			 name(s):
			 N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide]
			 -------- 9855-(5-2022)
(GG)
			 4'-Methyl acetyl fentanyl [other name(s): N-(1-(4-methylphenethyl)
			 piperidin-4-yl)-N-phenylacetamide]
			 --------------------------------------------- 9819-(5-2022)
(HH) Ortho-fluorobutyryl fentanyl [other
			 name(s): N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide]
			 ----------------------------------------- 9846-(5-2022)
(II) Ortho-methyl acetylfentanyl [other
			 name(s): N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide]
			 ---------------------------------------------- 9848-(5-2022)
(JJ) Ortho-methyl methoxyacetyl fentanyl
			 [other name(s):
			 2-methoxy-N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide]
			 -------------------- 9820-(5-2022)
(KK) Para-methylfentanyl [other name(s):
			 N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)propionamide]
			 ----------------------------------------- 9817-(5-2022)
(LL) Phenyl fentanyl [other name(s):
			 N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide]
			 ------------------------------------------------------------------
			 9841-(5-2022)
(MM) Thiofuranyl
			 fentanyl [other name(s):
			 N-(1-phenethylpiperidin-4-yl)-N-phenylthiophene-2-carboxamide]
			 --------------------------------------------- 9839-(5-2022)
(NN) Fentanyl carbamate [other name(s):
			 ethyl(1-phenethylpiperidin-4-yl)(phenyl)carbamate]
			 -------------------------------------------------------------
			 9851-(5-2022)
(OO)
			 Ortho-fluoroacryl fentanyl [other name(s):
			 N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)acrylamide]
			 --------------------------------------------- 9852-(5-2022)
(PP) Ortho-fluoroisobutyryl fentanyl [other
			 name(s): N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide]
			 ---------------------------------- 9853-(5-2022)
(QQ) Para-fluoro furanyl fentanyl [other
			 name(s): N-(4-fluorophenyl)-N- (1-phenethylpiperidin-4-yl)furan-2-carboxamide]
			 ----------------------------- 9854-(5-2022)
(52) Zipeprol
			 ------------------------------------------------------------------------------------------------
			 9873
(53) Brorphine
			 ---------------------------------------------------------------------------------------------
			 9098
(54) Benzimidazole-opioid
			 substances, their isomers, esters, ethers, salts and salts of isomers, esters
			 and ethers. Benzimidazole-opioid substances includes any substance, not
			 otherwise listed or excepted, and for which no exemption or approval is in
			 effect under Section 505 of the Federal Food, Drug, and Cosmetic Act
			 [21 U.S.C.
			 355], that structurally has benzimidazole
			 ring with an ethylamine at its 1-position and benzyl group at its 2-position:
(i) With or without substitution on the
			 benzimidazole;
(ii) With or without
			 substitution at the ethylamine;
(iii) With or without inclusion of the
			 ethylamine in a cyclic structure;
(iv) With or without substitution on the
			 benzyl ring; or
(v) With or without
			 replacement of the benzyl ring with an aromatic ring.
(vi) Benzimidazole-opioid substances shall
			 include but are not limited to:
(A) 4'-Hydroxy
			 Nitazene;
(B)
			 5-Aminoisotonitazene;
(C)
			 Butonitazene;
(D) Clonitazene;
			 -----------------------------------------------------------------------------------
			 9612 *
(E) Etodesnitazene, [other
			 name(s): Etazene];
(F) Etonitazene;
			 ----------------------------------------------------------------------------------
			 9624*
(G) Flunitazene;
(H) Isotonitazene;
			 -----------------------------------------------------------------------------------
			 9614
(I)
			 Isotodesnitazene;
(J)
			 Metodesnitazene;
(K) Metonitazene;
			 -----------------------------------------------------------------------------------
			 9757
(L) N-Desethyl
			 Etonitazene;
(M) N-Desethyl
			 Isotonitazene;
(N) N-Piperidinyl
			 Etonitazene [other name(s): Etonitazepipne];
(O) N-Pyrrolidino Etonitazene [other name(s):
			 Etonitazepyne];
(P) N-Pyrrolidino
			 Protonitazene; and
(Q)
			 Protonitazene.
(c)
Opium derivatives: (Narcotic
			 Drugs
) Unless specifically excepted or unless listed in another
			 schedule, any of the following opium derivatives, its salts, isomers, and salts
			 of isomers whenever the existence of such salts, isomers, and salts of isomers
			 is possible within the specific chemical designation:
(1) Acetorphine
			 --------------------------------------------------------------------------------------------
			 9319*
(2) Acetyldihydrocodeine
			 --------------------------------------------------------------------------------
			 9051*
(3) Benzylmorphine
			 ---------------------------------------------------------------------------------------
			 9052*
(4) Codeine methylbromide
			 ------------------------------------------------------------------------------
			 9070*
(5) Codeine-N-Oxide
			 -------------------------------------------------------------------------------------
			 9053*
(6) Cyprenorphine
			 -----------------------------------------------------------------------------------------
			 9054*
(7) Desomorphine
			 -----------------------------------------------------------------------------------------
			 9055*
(8) Dihydromorphine
			 -------------------------------------------------------------------------------------
			 9145*
(9) Drotebanol
			 ---------------------------------------------------------------------------------------------
			 9335*
(10) Etorphine (except
			 hydrochloride salt) ----------------------------------------------------------
			 9056*
(11) Heroin
			 -----------------------------------------------------------------------------------------------
			 9200*
(12) Hydromorphinol
			 -----------------------------------------------------------------------------------
			 9301*
(13) Methyldesorphine
			 ----------------------------------------------------------------------------------
			 9302*
(14) Methyldihydromorphine
			 --------------------------------------------------------------------------
			 9304*
(15) Morphine methylbromide
			 ------------------------------------------------------------------------
			 9305*
(16) Morphine methylsulfonate
			 -----------------------------------------------------------------------
			 9306*
(17) Morphine-N-Oxide
			 --------------------------------------------------------------------------------
			 9307*
(18) Myrophine
			 ------------------------------------------------------------------------------------------
			 9308*
(19) Nicocodeine
			 ----------------------------------------------------------------------------------------
			 9309*
(20) Nicomorphine
			 --------------------------------------------------------------------------------------
			 9312*
(21) Normorphine
			 ---------------------------------------------------------------------------------------
			 9313*
(22) Pholcodine
			 ------------------------------------------------------------------------------------------
			 9314*
(23) Thebacon
			 --------------------------------------------------------------------------------------------
			 9315*
(24) Mitragynine
			 -------------------------------------------------------------------------------------
			 (11-2015)
(25)
			 7-Hydroxymitragynine---- ------------------------------------
			 --------------------------------- (11-2015)
(d)
Hallucinogenic substances:
Unless specifically excepted or unless listed in another schedule, any
			 material, compound, mixture, or preparation, which contains any quantity of the
			 following hallucinogenic substance, or which contains any of its salts,
			 isomers, and salts of isomers whenever the existence of such salts, isomers,
			 and salts of isomers is possible within the specific chemical designation (for
			 purposes of this paragraph only, the term "isomer" includes the optical,
			 position and geometric isomers):
(1)
			 alpha-ethyltryptamine
			 ---------------------------------------------------------------------
			 7249-(12-1993)
Some trade or other names: etryptamine; Monase;
				alpha-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl)indole; alpha-ET; and
				AET.
(2)
			 4-bromo-2,5-dimethoxy-amphetamine
			 ------------------------------------------------------------ 7391*
Some trade or other names:
				4-bromo-2,5-dimethoxy-alpha-methylphenethylamine; 4-bromo-2,5-DMA.
(3)
			 4-bromo-2,5-dimethoxyphenethylamine
			 ------------------------------------------------ 7392-(8-1995)
Some trade or other names: 2-(4-bromo-2,5-dimethoxyphenyl)-1
				aminoethane; alpha-desmethyl DOB; 2C-B, Nexus.
(4) 2,5-dimethoxyamphetamine
			 ------------------------------------------------------------------------- 7396*
Some trade or other names:
				2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA.
(5) 2,5-dimethoxy-4-ethylamphetamine
			 ----------------------------------------------------- 7399-(3-1988)
Some trade or other names: DOET.
(6)
			 2,5-dimethoxy-4-(n)-propylthiophenethylamine
			 ----------------------------------------- 7348-(1-2005)
Some trade or other names: 2C-T-7.
(7) 4-methoxyamphetamine
			 ------------------------------------------------------------------------------
			 7411*
Some trade or other names: 4-methoxy-alpha-
				methylphenethylamine; paramethoxyamphetamine; PMA.
(8) 5-methoxy-3,4-methylenedioxy-amphetamine
			 --------------------------------------------------- 7401*
(9) 4-methyl-2,5-dimethoxyamphetamine
			 ------------------------------------------------------------- 7395*
Some trade and other names:
				4-methyl-2,5-dimethoxy-alphamethylphenethylamine; "DOM"; and "STP".
(10) 3,4-methylenedioxy
			 amphetamine --------------------------------------------------------------
			 7400*
(11)
			 3,4-methylenedioxymethamphetamine
			 ---------------------------------------------- 7405-(10-1985)
Some trade or other names: MDMA)
(12) 3,4-methylenedioxy-N-ethylamphetamine
			 -------------------------------------------- 7404-(6-1990)
Some trade or other names: N- ethy-alpha-methyl-3,4
				(methylenedioxy) phenethylamine, N-ethyl MDA; MDE; MDEA.
(13) N-hydroxy-3,4-methylenedioxyamphetamine
			 ---------------------------------------- 7402-(6-1990)
Some trade or other names:
				N-hydroxy-alpha-methyl-3,4(methylenedioxy) phenethylamine; N-hydroxy MDA
(14) 3,4,5-trimethoxy amphetamine
			 ------------------------------------------------------------------
			 7390*
(15)
			 5-methoxy-n,n-dimethyltryptamine 5-MeO-DMT -----------------------------------
			 7431*(1-2011)
(16)
			 alpha-methyltryptamine
			 ---------------------------------------------------------------- 7432-(7-2005)
Some trade or other names: AMT
(17) Bufotenine
			 ------------------------------------------------------------------------------------------
			 7433*
Some trade and other names:
				3-(beta-Dimethylaminoethyl)-5-hydroxyindole;
				3-(2-dimethylaminoethyl)-5-indolol; N,N-dimethylserotonin;
				5-hydroxy-N,N-dimethyltryptamine; mappine.
(18) Diethyltryptamine
			 ---------------------------------------------------------------------------------
			 7434*
Some trade or other names: N,N-Diethyltryptamine;DET.
(19) Dimethyltryptamine
			 -------------------------------------------------------------------------------
			 7435*
Some trade or other names: DMT
(20) 5-methoxy-N,N-diisopropyltryptamine
			 ---------------------------------------------- 7439-(7-2005)
Some trade or other names: 5-MeO-DIPT.
(21) Ibogaine
			 ---------------------------------------------------------------------------------------------
			 7260*
Some trade and other names: 7-Ethyl-6,6 beta;
				7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido [1',2': 1,2] azepino
				[5,4-b] indole; Tabernanthe iboga.
(22) Lysergic acid diethylamide
			 -----------------------------------------------------------------------
			 7315*
(23) Mescaline
			 -------------------------------------------------------------------------------------------
			 7381*
(24) Parahexyl
			 ---------------------------------------------------------------------------------
			 7374-(7-1983)
Some trade or other names:
				3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo [b,d] pyran;
				Synhexyl.
(25) Peyote
			 -----------------------------------------------------------------------------------------------
			 7415*
Meaning all parts of the plant presently classified botanically
				as Lophophora williamsii Lemaire, whether growing or not; the seeds thereof;
				any extract from any part of such plant; and every compound, manufacture,
				salts, derivative, mixture or preparation of such plant, its seeds or extracts.
				(Interprets 21 USC
				812 (c), Schedule I (c)
				(12)).
(26)
			 N-ethyl-3-piperidyl benzilate
			 --------------------------------------------------------------------
			 7482*
(27) N-methyl-3-piperidyl
			 benzilate ------------------------------------------------------------------
			 7484*
(28) Psilocybin
			 -------------------------------------------------------------------------------------------
			 7437*
(29) Psilocyn
			 ---------------------------------------------------------------------------------------------
			 7438*
(30) Ethylamine Analog of
			 phencyclidine ----------------------------------------------------------- 7455*
Some trade or other names: N-ethyl-1-phenylcyclohexylamine,
				(phenylcyclohexyl)ethylamine; N-(1-phenylcyclohexyl)ethylamine; cyclohexamine;
				PCE.
(31) Pyrrolidine
			 Analog of phencyclidine
			 ----------------------------------------------------------- 7458*
Some trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine;
				PCPy; PHP
(32) Thiophene
			 Analog of phencyclidine
			 ------------------------------------------------------------ 7470*
Some trade or other names: 1-[1-(2-thienyl) cyclohexyl]
				Piperidine; 2-Thienyl analog of phencyclidine; TPCP; TCP.
(33) 1-[1-(2-Thienyl)cylcohexyl]pyrrolidine
			 ---------------------------------------------- 7473-(9-1989)
Some other trade or other names: TCPy.
(34) N,N-Diallyl-5-Methoxytryptamine;
			 ----------------------------------------------------------- (6-2012)
Some trade or other names: 5-MeO DALT; 5-Methoxy-DALT
(35)
			 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine;
			 25C-NBOMe
			 -----------------------------------------------------------------------------------------
			 (5-2013)
(36)
			 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl) methyl]ethanamine;
			 25I-NBOMe
			 ------------------------------------------------------------------------------------------
			 (8-2013)
(37)
			 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine; 2C-E
			 -------------------------------- 7509-(11-2013)
(38)
			 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine; 2C-D ----------------------------
			 7508-(11-2013)
(39)
			 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine; 2C-C ------------------------------
			 7519-(11-2013)
(40)
			 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine; 2C-I
			 ---------------------------------- 7518-(11-2013)
(41)
			 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine; 2C-T-2 ----------------------
			 7385-(11-2013)
(42)
			 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine; 2C-T-4 -----------------
			 7532-(11-2013)
(43)
			 2-(2,5-Dimethoxyphenyl)ethanamine; 2C-H
			 ----------------------------------------- 7517-(11-2013)
(44)
			 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine; 2C-N
			 ------------------------------- 7521-(11-2013)
(45)
			 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine; 2C-P -------------------------
			 7524-(11-2013)
(46)
			 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine; 25B-NBOMe
			 -----------------------------------------------------------------------------------------------
			 (9-2018)
(47)
			 2-[[[2-(4-bromo-2,5-dimethoxyphenyl)ethyl]amino]methyl]-phenol; 25B-NBOH
			 -----------------------------------------------------------------------------------------------
			 (11-2018)
(48)
			 2-[[[2-(4-iodo-2,5-dimethoxyphenyl)ethyl]amino]methyl]-phenol; 25I-NBOH -------
			 (11-2018)
(49)
			 2-(4-ethyl-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl) methyl]ethanamine;
			 25E-NBOMe
			 -----------------------------------------------------------------------------------------
			 (7-2019)
(50)
			 2-(2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl) methyl]ethanamine; 25H-NBOMe
			 -----------------------------------------------------------------------------------------------
			 (7-2019)
(51)
			 2-[[[2-(4-chloro-2,5-dimethoxyphenyl)ethyl]amino]methyl]- phenol; 25C-NBOH
			 -------------------------------------------------------------------------------------------------
			 (7-2019)
(52)
			 2-[[[2-(2,5-dimethoxyphenyl)ethyl]amino]methyl]-phenol; 25H-NBOH
			 ----------------- (7-2019)
(53)
			 1-(4-methoxyphenyl)-N-methylpropan-2-amine
			 ------------------------------------- 1245-(5-2022)
Some trade or other names: Para-methoxymethamphetamine;
				PMMA
(54)
			 2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one
			 ---------------------------------------- 7286
Some trade or other names: Methoxetamine; MXE
(e)
Depressants
:
			 Unless specifically excepted or unless listed in another schedule, any
			 material, compound, mixture, or preparation which contains any quantity of the
			 following substances having a depressant effect on the central nervous system,
			 including its salts, isomers, and salts of isomers whenever the existence of
			 such salts, isomers, and salts of isomers is possible within the specific
			 chemical designation:
(1) gamma-hydroxybutyric
			 acid [other name(s): GHB; gamma-hydroxybutyrate; 4-hydroxybutyrate;
			 4-hydroxydutanoic acid; sodium oxybate; sodium oxybutyrate], and its known
			 precursors and analogs. Precursors include but are not limited to:
			 gamma-butyrolactone
			 -----------------------------------------------------------------------
			 2010-(2-2001)
(2) Mecloqualone
			 -----------------------------------------------------------------------------------------
			 2572*
(3) Methaqualone
			 ------------------------------------------------------------------------------------------
			 2565*
(4) Benzodiazepine
			 substances, their isomers, esters, ethers, salts and salts of isomers, esters
			 and ethers. Benzodiazepine substances includes any substance, not otherwise
			 listed or excepted, and for which no exemption or approval is in effect under
			 section 505 of the Federal Food, Drug, and Cosmetic Act [21 U.S.C.
			 355], that structurally has a fused
			 1,4-diazepine and benzene ring structure with a phenyl connected to the
			 diazepine ring, with any substitution(s) or replacement(s) on the 1,4-diazepine
			 or benzene ring, any substitution(s) on the phenyl ring, or any combination
			 thereof. Benzodiazepine substances shall include but are not limited to:
(i) Bromazolam;
(ii) Clonazolam;
			 -----------------------------------------------------------------------------------
			 (4-2021)
(iii) Flualprazolam;
			 ---------------------------------------------------------------------------------
			 (4-2021)
(iv) Flubromazepam;
			 ------------------------------------------------------------------------------
			 (4-2021)
(v) Flubromazolam;
			 -------------------------------------------------------------------------------
			 (4-2021)
(vi) Phenazepam;
			 -----------------------------------------------------------------------------------
			 (6-2012)
(vii) Phenazolam [other
			 name(s): Clobromazolam].
(5) Thienodiazepine substances, their
			 isomers, esters, ethers, salts and salts of isomers, esters and ethers.
			 Thienodiazepine substances includes any substance, not otherwise listed or
			 excepted, and for which no exemption or approval is in effect under section 505
			 of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 355], that
			 structurally has a fused 1,4-diazepine and thiophene ring structure with a
			 phenyl connected to the 1,4-diazepine ring, with any substitution(s) or
			 replacement(s) on the 1,4-diazepine or thiophene ring, any substitution(s) on
			 the phenyl ring, or any combination thereof. Thienodiazepine substances shall
			 include but are not limited to:
(i) Etizolam
			 --------------------------------------------------------------------------------------
			 (12-2014)
(f)
Stimulants
:
(1) Unless
			 specifically excepted or unless listed in another schedule, any material,
			 compound, mixture, or preparation which contains any quantity of the following
			 substances having a stimulant effect on the central nervous system, including
			 its salts, isomers, and salts of isomers:
(i)
			 Cathinone
			 ------------------------------------------------------------------------------
			 1235-(3-1988)
(ii) (+)
			 CIS-4-Methylaminorex [(+)CIS-4,5-dihydro-4- methyl-5-phenyl-2-oxazolamine]
			 -----------------------------------------------------------------------
			 1590-(6-1990)
(iii) Fenethylline
			 ---------------------------------------------------------------------------
			 1503-(9-1981)
(iv)
			 N-Benzylpiperazine
			 -------------------------------------------------------------------
			 7493-(1-2005)
Some trade or other names: BZP, 1-Benzylpiperazine
(v) N-ethylamphetamine
			 -----------------------------------------------------------------
			 1475-(6-1982)
(vi)
			 N-[1-(1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl), its optical
			 isomers, salts and salts of isomers ---------------------------------------
			 9818-(2-1986)
(vii)
			 N-[1-(2-thienyl)methyl-4-piperidyl)-N-phenylpropan-mide (thenylfentanyl), its
			 optical isomers, salts and salts of isomers -----------------------------------
			 9834-(2-1986)
(viii)
			 N,N-Dimethylamphetamine [other name(s): N,N,Alpha- trimethylbenzeneethanamine;
			 N,N,Alpha-trimethylphenethylamine], its salts, optical isomers, and salts of
			 optical isomers ---------------------------- 1480-(2-1989)
(ix) Methcathinone (some other names:
			 2-Methylamine-Proprophenone, alpha (methylamino)- Proprophenone, 2
			 (methylamino)-1-phenylpropan-1-one, alpha-N-Methylaminopropiophenone,
			 monomethylpropion, ephedrone, N-methylcathinone, methycathinone, AL-464,
			 AL-422, AL-463 and UR-1431), its salts, optical isomers and salts of optical
			 isomers-----------------1237-(12-1993)
(x) Aminorex [other name(s): aminoraphen,
			 2-amino-5 phenyl-2-oxazoline, or 4,5 dihyrdo-5-phenyl-2-oxazolamine], its
			 salts, optical isomers, and salts of optical isomers
			 ----------------------------------------------------------------
			 1585-(12-1993)
(xi)
			 4,4'-Dimethylaminorex some other names: 4,4'-DMAR,
			 4,5-dihydro-4-methyl-5-(4-methylphenyl)-2-oxazolamine, or
			 4-methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine
			 ------------------------------ 1595-(5-2022)
(xii)
			 Amineptine----------------------------------------------------------------------------------------1219
(xiii)
			 Mesocarb-------------------------------------------------------------------------------------------1227
(xiv) Methyl-N-ethylcathinone
			 (MEC)-----------------------------------------------------------(6-2014)
(xv) Methiopropamine. [other name(s):
			 N-methyl-1-(thiophen-2-yl)propan-2-amine]--------------------------------------------------------------------------------------------1478
(2) Any material, compound,
			 mixture, or preparation, whether produced directly or indirectly from a
			 substance of vegetable origin or independently by means of chemical synthesis
			 or by a combination of extraction and chemical synthesis, that contains any
			 quantity of the following substances, or that contains any of the following
			 substances' analogs, salts, isomers, and salts of isomers when the existence of
			 the analogs, salts, isomers, and salts of isomers is possible within the
			 specific chemical designation, with the following chemical structure is
			 included in Schedule I:
(i)
			 4-Methylmethcathinone (Mephedrone) -------------------------------------------
			 1248-(3-2011)
(ii)
			 Methylenedioxypyrovalerone
			 (MDPV)-------------------------------------------------- (3-2011)
(iii) 3,4-Methylenedioxy-N-methylcathinone
			 (Methylone---------------------------- 7540-(3-2011)
(iv)
			 4-Methoxymethcathinone-------------------------------------------------------------------(3-2011)
(v)
			 3-Fluoromethcathinone---------------------------------------------------------------------
			 (3-2011)
(vi)
			 4-Fluoromethcathinone-----------------------------------------------------------------------(3-2011)
(vii)
			 1-(1,3-benzodioxol-5-yl)-2-methylamino)butan-1-one-(Butylone)-----------7541-(11-2014)
(viii) Alpha-Pyrrolidinopentiophenone
			 (Alpha-PVP)---------------------------------7545-(11-2015)
(ix) 4-methyl-N-ethylcathinone
			 (4-MEC)-----------------------------------------------1249-(9-2018)
(x) 4-methyl-alpha-pyrrolidinopropiophenone
			 (4-MePPP)---------------------------7498-(9-2018)
(xi) 2-(methylamino)-1-phenylpentan-1-one
			 (Pentedrone)----------------------------1246-(9-2018)
(xii)
			 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one (Pentylone;
			 bk-MBDP)--------------------------------------------------------------------------------7542-(9-2018)
(xiii) 4-fluoro-N-methylcathinone (4-FMC,
			 Flephedrone)-----------------------------1238-(9-2018)
(xiv) 3-fluoro-N-methylcathinone
			 (3-FMC)----------------------------------------------1233-(9-2018)
(xv)
			 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one
			 (Naphyrone)-------------1258-(9-2018)
(xvi) Alpha-pyrrolidinobutiophenone
			 ([Alpha]-PBP) ----------------------------------7546-(9-2018)
(xvii) A compound, unless listed in another
			 schedule or a legend drug, that is structurally derived from
			 2-Amino-phenyl-1-propanone by modification or by
			 substitution:------------------------------------------------------------------------------(3-2012)
(A) In the phenyl ring to any extent with
			 alkyl, alkoxy, alkylenedioxy, haloalkyl or halide substituents, whether or not
			 further substituted in the phenyl ring by one (1) or more other univalent
			 substituents;
(B) At the 3-position
			 with an alkyl substituent; or
(C)
			 At the nitrogen atom with alkyl or dialkyl groups, or by inclusion of the
			 nitrogen atom in a cyclic structure.
(xviii)
			 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)pentan-1-one (N-Ethylpentylone)
			 7543-(7-2019)
(xix)
			 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)propan-1-one
			 (Ethylone)--------------7547-(4-2021)
(xx)
			 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-1-butanone (Eutylone)
			 --------------7549-(4-2021)
(xxi)
			 2-(ethylamino)-1-phenylhexan-1-one [other name(s): (N-Ethylhexedrone;
			 Alpha-Ethylaminohexanophenone)]---------------------------------------------------------7246
(xxii)
			 1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one [other name(s): (Alpha-
			 Pyrrolidinohexanophenone;
			 Alpha-PHP)]--------------------------------------------------7544
(xxiii)
			 2-(ethylamino)-1-(4-methylphenyl)pentan-1-one [other name(s): (4-
			 Methyl-alpha-ethylaminopentiophenone;
			 4-MEAP)]-------------------------------------7245
(xxiv)
			 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one [other name(s): (4'-
			 Methyl-alpha-pyrrolidinohexiophenone; MPHP)]
			 ---------------------------------------7446
(xxv)
			 1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one [other name(s): (Alpha-
			 Pyrrolidinoheptaphenone;
			 PV8)]------------------------------------------------------------7548
(xxvi)
			 1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one [other name(s): (4'-
			 Chloro-alpha-pyrrolidinovalerophenone;
			 4-chloro-alpha-PVP)]------------------------7443
SCHEDULE II
(a) Schedule II shall consist of the drugs
			 and other substances, by whatever official name, common or usual name, chemical
			 name, or brand name designated, listed in this section. Each drug or substance
			 has been assigned the Controlled Substances Code Number set forth opposite
			 it.
(b)
Narcotic
			 Drugs:
Substances, vegetable origin or chemical synthesis. Unless
			 specifically excepted or unless listed in another schedule, any of the
			 following substances whether produced directly or indirectly by extraction from
			 substances of vegetable origin, or independently by means of chemical
			 synthesis, or by combination of extraction and chemical synthesis:
(1) Opium and opiate, and any salt, compound,
			 derivative, or preparation of opium or opiate excluding apomorphine,
			 thebaine-derived butorphanol, dextrorphan, nalbuphine, naldemedine, nalmefene,
			 naloxegol, naloxone, 6ß-naltrexol, naltrexone and samidorphan, and their
			 respective salts, but including the following:
(i) Raw opium
			 --------------------------------------------------------------------------------------
			 9600*
(ii) Opium extracts
			 ----------------------------------------------------------------------------------
			 9610*
(iii) Opium fluid extracts
			 ---------------------------------------------------------------------------
			 9620*
(iv) Powdered opium
			 --------------------------------------------------------------------------------
			 9639*
(v) Granulated opium
			 ------------------------------------------------------------------------------
			 9640*
(vi) Tincture of opium
			 ------------------------------------------------------------------------------
			 9630*
(vii) Codeine
			 ------------------------------------------------------------------------------------------
			 9050*
(viii) Dihydroetorphine
			 -------------------------------------------------------------------------------
			 9334*
(ix) Ethylmorphine
			 ----------------------------------------------------------------------------------
			 9190*
(x) Etorphine hydrochloride
			 -----------------------------------------------------------------------
			 9059*
(xi) Hydrocodone
			 ------------------------------------------------------------------------------------
			 9193*
(xii) Hydromorphone
			 --------------------------------------------------------------------------------
			 9150*
(xiii) Metopon
			 -----------------------------------------------------------------------------------------
			 9260*
(xiv) Morphine
			 ----------------------------------------------------------------------------------------
			 9300*
(xv) Oripavine
			 -----------------------------------------------------------------------------
			 9330*(9-2007)
(xvi) Oxycodone
			 --------------------------------------------------------------------------------------
			 9143*
(xvii) Oxymorphone
			 -----------------------------------------------------------------------------------
			 9652*
(xviii) Thebaine
			 ---------------------------------------------------------------------------------------
			 9333*
(xix) Tapentadol
			 -----------------------------------------------------------------------------
			 9780-(5-2009)
(xx) Noroxymorphone
			 ---------------------------------------------------------------------
			 9668-(4-2021)
(2) Any
			 salt, compound, derivative, or preparation thereof which is chemically
			 equivalent or identical with any of the substances referred to in paragraph (b)
			 (1) of this section, except that these substances shall not include the
			 isoquinoline alkaloids of opium.*
(3) Opium poppy and poppy straw.*
(4) Coca leaves (9040) and any salt,
			 compound, derivative, or preparation of coca leaves, (including cocaine (9041)
			 and ecgonine (9180) and their salts, isomers, derivatives and salts of isomers
			 and derivatives), and any salt, compound, derivative, or preparation thereof
			 which is chemically equivalent or identical with any of these substances,
			 except that the substances shall not include: ---------------------------------
			 *
(i) Decocainized coca leaves or extraction
			 of coca leaves, which extractions do not contain cocaine or ecgonine;
			 ----------------------------------------------------------------- *
(ii)
			 [123I]ioflupane; or
(iii)
			 [18F]FP-CIT.
(5) Concentrate or poppy straw (the crude
			 extract of poppy straw in either liquid, solid or powder form which contains
			 the phenanthrene alkaloids of the opium poppy),
			 --------------------------------------------------------------------------------------------------
			 9670.*
(c)
Opiates: (Narcotic Drugs)
Unless specifically excepted or unless
			 in another schedule, any of the following opiates, including its isomers,
			 esters, ethers, salts, and salts of isomers, esters and ethers whenever the
			 existence of such isomers, esters, ethers, and salts is possible within the
			 specific chemical designations:
(1) Alfentanil
			 -------------------------------------------------------------------------------------
			 9737-(2-1987)
(2) Alphaprodine
			 ------------------------------------------------------------------------------------------
			 9010*
(3) Anileridine
			 ---------------------------------------------------------------------------------------------
			 9020*
(4) Bezitramide
			 --------------------------------------------------------------------------------------------
			 9800*
(5) Bulk Dextropropoxyphene
			 (non-dosage forms) -----------------------------------------
			 9273-(9-1981)
(6) Carfentanil
			 -----------------------------------------------------------------------------------
			 9743-(9-1988)
(7) Dihydrocodeine
			 ----------------------------------------------------------------------------------------
			 9120*
(8) Diphenoxylate
			 -----------------------------------------------------------------------------------------
			 9170*
(9) Fentanyl
			 ------------------------------------------------------------------------------------------------
			 9801*
(10) Isomethadone
			 ---------------------------------------------------------------------------------------
			 9226*
(11) Levo-alphacetylmethadol
			 (LAAM) --------------------------------------------------
			 9648-(12-1993)
(12) Levomethorphan
			 -----------------------------------------------------------------------------------
			 9210*
(13) Levorphanol
			 ----------------------------------------------------------------------------------------
			 9220*
(14) Metazocine
			 -----------------------------------------------------------------------------------------
			 9240*
(15) Methadone
			 ------------------------------------------------------------------------------------------
			 9250*
(16) Methadone-Intermediate,
			 4-cyano-2-dimethylamino-4, 4-diphenyl butane --------------- 9254*
(17) Moramide-Intermediate,
			 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid
			 ----------------------------------------------------------------------------------------
			 9802*
(18) Pethidine (Meperidine)
			 ---------------------------------------------------------------------------
			 9230*
(19)
			 Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine
			 -------------------------- 9232*
(20) Pethidine-Intermediate-B,
			 ethyl-4-phenylpiperidine-4-carboxylate -------------------------
			 9233*
(21)
			 Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid
			 --------------- 9234*
(22)
			 Phenazocine
			 ----------------------------------------------------------------------------------------
			 9715*
(23) Piminodine
			 ------------------------------------------------------------------------------------------
			 9730*
(24) Racemethorphan
			 -----------------------------------------------------------------------------------
			 9732*
(25) Racemorphan
			 ---------------------------------------------------------------------------------------
			 9733*
(26) Remifentanil
			 ----------------------------------------------------------------------------
			 9739-(11-1996)
(27) Sufentanil
			 ---------------------------------------------------------------------------------
			 9740-(9-1981)
(28) Thiafentanil
			 -------------------------------------------------------------------------------
			 9729-(4-2021)
(29) Oliceridine
			 --------------------------------------------------------------------------------
			 9245-(5-2022)
(30) Tianeptine
			 ----------------------------------------------------------------------------------------
			 (5-2022)
(d)
Stimulants:
Unless specifically excepted or unless listed in
			 another schedule, any material, compound, mixture, or preparation which
			 contains any quantity of the following substances having a stimulant effect on
			 the central nervous system:
(1) Amphetamine,
			 its salts, optical isomers, and salts of its optical isomers
			 ---------------------- 1100*
(2)
			 Methamphetamine, its salts, isomers, and salts of its isomers
			 ----------------------------------- 1105*
(3) Lisdexamefetamine
			 -------------------------------------------------------------------------
			 1205*(7-2007)
(4) Phenmetrazine and
			 its salts
			 --------------------------------------------------------------------------
			 1631*
(5) Methylphenidate
			 --------------------------------------------------------------------------------------
			 1724*
(e)
Depressants:
Unless specifically excepted or unless listed in
			 another schedule, any material, compound, mixture, or preparation which
			 contains any quantity of the following substances having a depressant effect on
			 the central nervous system, including its salts, isomers, and salts of isomers
			 whenever the existence of such salts, isomers, and salts of isomers is possible
			 within the specific chemical designation:
(1)
			 Amobarbital
			 --------------------------------------------------------------------------------------------
			 2125*
(2) Glutethimide
			 ---------------------------------------------------------------------------------
			 2550-(2-1991)
(3) Pentobarbital
			 -------------------------------------------------------------------------------------------
			 2270*
(4) Phencyclidine
			 ------------------------------------------------------------------------------------------
			 7471*
(5) Secobarbital
			 --------------------------------------------------------------------------------------------
			 2315*
(f)
Hallucinogenic Substances:
(1)
			 Nabilone
			 -------------------------------------------------------------------------------------
			 7379-(11-1987)
[Other name(s) for nabilone:
				(+)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,6-dimethyl-9H-dibenzo[b,d]pyran-9-one].
(2) Dronabinol in an oral solution
			 in a drug product approved for marketing by the U.S. Food and Drug
			 Administration; [(-)-delta-9-trans-tetrahydrocannabinol(delta-9-THC)].
			 ------------------------------------------------------ 7365-(7-2019)
(g)
Immediate
			 Precursor:
Unless specifically excepted or unless listed in another
			 schedule, any material, compound, mixture, or preparation which contains any
			 quantity of the following substances:
(1)
			 Immediate precursor to Amphetamine and Methamphetamine:
(i) Phenylacetone
			 -------------------------------------------------------------------------
			 8501-(3-1980)
Some trade or other names: phenyl-2-propanone; P2P; benzyl
				methyl Ketone; methyl benzyl Ketone.
(2) Immediate precursor to Phencyclidine
			 (PCP):
(i) 1-phenylcyclohexylamine
			 ---------------------------------------------------------------------
			 7460*
(ii)
			 1-piperidinocyclohexanecarbonitrile (PCC)
			 ------------------------------------------------- 8603*
(3) Immediate precursor to Fentanyl:
(i) 4-anilino-N-phenethylpiperidine (ANPP)
			 ---------------------------------------- 8333*(8-2010)
(ii) N-phenyl-N-(piperidin-4-yl)propionamide
			 (norfentanyl) ----------------------- 8366-(4-2021)
SCHEDULE III
(a) Schedule III shall consist of the drugs
			 and other substances, by whatever official name, common or usual name, chemical
			 name, or brand name designated, listed in this section. Each drug or substance
			 has been assigned the DEA Controlled Substances Code Number set forth opposite
			 it.
(b)
Stimulants:
Unless specifically excepted or unless listed in another schedule, any
			 material, compound, mixture, or preparation which contains any quantity of the
			 following substances having a stimulant effect on the central nervous system,
			 including its salts, isomers (whether optical, position, or geometric), and
			 salts of such isomers whenever the existence of such salts, isomers, and salts
			 of isomers is possible within the specific chemical designation:
(1) Those compounds, mixtures, or
			 preparations in dosage unit form containing any stimulant substances listed in
			 Schedule II which compounds, mixtures, or preparations were listed on August
			 25, 1971, as excepted compounds under Section 308.32, and any other drug of the
			 quantitative composition shown in that list for those drugs or which is the
			 same except that it contains a lesser quantity of controlled substances
			 ----------------------------------------------------------------------------------
			 1405*
(2) Benzphetamine
			 ----------------------------------------------------------------------------------------
			 1228*
(3) Chlorphentermine
			 -------------------------------------------------------------------------------------
			 1645*
(4) Clortermine
			 --------------------------------------------------------------------------------------------
			 1647*
(5) Phendimetrazine
			 ---------------------------------------------------------------------------------------
			 1615*
(c)
Depressants:
Unless specifically excepted or unless listed in
			 another schedule, any material, compound, mixture, or preparation which
			 contains any quantity of the following substances having a depressant effect on
			 the central nervous system:
(1) Any compound,
			 mixture, or preparation containing:
(i)
			 Amobarbital
			 -------------------------------------------------------------------------------------
			 2126*
(ii) Secobarbital
			 -------------------------------------------------------------------------------------
			 2316*
(iii) Pentobarbital
			 ------------------------------------------------------------------------------------
			 2271*
(iv) Embutramide
			 -------------------------------------------------------------------------
			 2020*(9-2006)
or any salt thereof and one or more other active medicinal
				ingredients which are not listed in any schedule.
(2) Any suppository dosage form containing:
(i) Amobarbital
			 -------------------------------------------------------------------------------------
			 2126*
(ii) Secobarbital
			 -------------------------------------------------------------------------------------
			 2316*
(iii) Pentobarbital
			 ------------------------------------------------------------------------------------
			 2271*
or any salt of any of these drugs and approved by the Food and
				Drug Administration for marketing only as a suppository.
(3) Any substance which contains
			 any quantity of a derivative of barbituric acid or any salt thereof
			 -----------------------------------------------------------------------------------------
			 2100*
(4) Chlorhexadol
			 -------------------------------------------------------------------------------------------
			 2510*
(5) Any drug product
			 containing gamma hydroxybutyric acid, including its salts, isomers, and salts
			 of isomers, for which an application is approved under section 505 of the
			 Federal Food, Drug, and Cosmetic Act ---------------------------------------
			 2012-(2-2001)
(6) Ketamine. its
			 salts, isomers, and salts of isomers ----------------------------------------
			 7285-(7-1999)
Some other names for Ketamine:
				(+-)-2-(2-Chlorophenyl)-2-(Methylamino)-Cyclohexanone.
(7) Lysergic acid
			 -------------------------------------------------------------------------------------------
			 7300*
(8) Lysergic acid amide
			 ----------------------------------------------------------------------------------
			 7310*
(9) Methyprylon
			 -------------------------------------------------------------------------------------------
			 2575*
(10) Sulfondiethylmethane
			 ------------------------------------------------------------------------------
			 2600*
(11) Sulfonethylmethane
			 -------------------------------------------------------------------------------
			 2605*
(12) Sulfonmethane
			 -------------------------------------------------------------------------------------
			 2610*
(13) Tiletamine and zolazepam
			 or any salt thereof ---------------------------------------- 7295-(3-1988)
Some trade or other name for a tiletamine- zolazepam
				combination product: Telazol.
Some trade or other names for tiletamine:
				-2(ethylamino)-2-(2-thienyl)-cyclohexanone.
Some trade or other names for zolazepam:
				-4(2-fluorophenyl)-6,8-dihydro-1,3,8,-trimethylpyrazolo-[3,4-e]
				[1,4,]-diazepin-7(1-H)-one. flupyrazapon.
(14) Perampanel
			 -----------------------------------------------------------------------------
			 2261-(11-2013)
(d)
			 Nalorphine
			 --------------------------------------------------------------------------------------------------
			 9400*
(e)
Narcotic
			 drugs:
Unless specifically excepted or unless listed in another
			 schedule:
(1) Any material, compound, mixture,
			 or preparation containing any of the following narcotic drugs, or their salts
			 calculated as the free anhydrous base or alkaloid, in limited quantities as set
			 forth below:
(i) Not more than 1.8 grams of
			 codeine per 100 milliliters or not more than 90 milligrams per dosage unit,
			 with an equal or greater quantity of an isoquinoline alkaloid of opium
			 ------------------------------------------------------------ 9803*
(ii) Not more than 1.8 grams of codeine per
			 100 milliliters or not more than 90 milligrams per dosage unit, with one or
			 more active, nonnarcotic ingredients in recognized therapeutic amounts
			 ------------------------------------------- 9804*
(iii) Not more than 1.8 grams of
			 dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage
			 unit, with one or more active nonnarcotic ingredients in recognized therapeutic
			 amounts ------------------------------------------- 9807*
(iv) Not more than 300 milligrams of
			 ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage
			 unit, with one or more active, nonnarcotic ingredients in recognized
			 therapeutic amounts ---------------------------- 9808*
(v) Not more than 500 milligrams of opium per
			 100 milliliters or per 100 grams or not more than 25 milligrams per dosage
			 unit, with one or more active nonnarcotic ingredients in recognized therapeutic
			 amounts ---------------------------- 9809*
(vi) Not more than 50 milligrams of morphine
			 per 100 milliliters or per 100 grams, with one or more active, nonnarcotic
			 ingredients in recognized therapeutic amounts
			 -------------------------------------------------------------------------
			 9810*
(2) Any material,
			 compound, mixture, or preparation containing any of the following narcotic
			 drugs or their salts, as set forth below:
(i)
			 Buprenorphine
			 ------------------------------------------------------------------------
			 9064-(6-1985) (10-02 Transfer)
(ii) Reserved
(f) Anabolic Steroids: Unless specifically
			 excepted or unless listed in another schedule, any material, compound, mixture,
			 or preparation containing any quantity of the following substances, including
			 its salts, isomers, and salts of isomers whenever the existence of such salts
			 of isomers is possible within the specific chemical designation:
			 ------------------------------------------------------------------------ 4000
(1) Boldenone;
			 --------------------------------------------------------------------------------------------
			 (9-1991)
(2) Boldione;
			 ----------------------------------------------------------------------------------------------
			 (1-2010)
(3) Chlorotestosterone
			 (4-chlortestosterone); --------------------------------------------------------
			 (9-1991)
(4) Clostebol;
			 ---------------------------------------------------------------------------------------------
			 (9-1991)
(5)
			 Dehydrochlormethyltestosterone;
			 -----------------------------------------------------------------
			 (9-1991)
(6)
			 Desoxymethyltestosterone
			 --------------------------------------------------------------------------
			 (1-2010)
(7) Dihydrotestosterone
			 (4-dihydrotestosterone); ---------------------------------------------------
			 (9-1991)
(8) Drostanolone;
			 -----------------------------------------------------------------------------------------
			 (9-1991)
(9) Ethylestrenol;
			 -----------------------------------------------------------------------------------------
			 (9-1991)
(10) Fluoxymesterone;
			 --------------------------------------------------------------------------------
			 (9-1991)
(11) Formebulone
			 (formebolone);
			 -------------------------------------------------------------------
			 (9-1991)
(12) Mesterolone;
			 --------------------------------------------------------------------------------------
			 (9-1991)
(13) Methandienone, also
			 known as Methandrostenolone; ---------------------------------------
			 (9-1991)
(14) Methandranone;
			 -----------------------------------------------------------------------------------
			 (9-1991)
(15) Methandriol;
			 ---------------------------------------------------------------------------------------
			 (9-1991)
(16) Methenolone;
			 --------------------------------------------------------------------------------------
			 (9-1991)
(17) Methyltestosterone;
			 ------------------------------------------------------------------------------
			 (9-1991)
(18) Mibolerone;
			 ---------------------------------------------------------------------------------------
			 (9-1991)
(19) Nandrolone;
			 ---------------------------------------------------------------------------------------
			 (9-1991)
(20)
			 19-Nor-4,9(10)-Androstadienedione
			 ---------------------------------------------------------- (1-2010)
(21) Norethandrolone;
			 ---------------------------------------------------------------------------------
			 (9-1991)
(22) Oxandrolone;
			 --------------------------------------------------------------------------------------
			 (9-1991)
(23) Oxymesterone;
			 ------------------------------------------------------------------------------------
			 (9-1991)
(24) Oxymetholone;
			 ------------------------------------------------------------------------------------
			 (9-1991)
(25) Stanolone;
			 -----------------------------------------------------------------------------------------
			 (9-1991)
(26) Stanozolol;
			 -----------------------------------------------------------------------------------------
			 (9-1991)
(27) Testolactone;
			 --------------------------------------------------------------------------------------
			 (9-1991)
(28) Testosterone;
			 --------------------------------------------------------------------------------------
			 (9-1991)
(29) Trenbolone
			 ----------------------------------------------------------------------------------------
			 (9-1991)
(30) Prostanozol
			 ----------------------------------------------------------------------------------------
			 (8-2012)
(31) Methasterone
			 -------------------------------------------------------------------------------------
			 (8-2012); and
(32) Any salt, ester,
			 or isomer of a drug or substance described or list in this paragraph, if that
			 salt, ester, or isomer promotes muscle growth. -----------------------------
			 (9-1991)
(g) Exempt
			 anabolic steroid products: Compounds, mixtures, or preparations that contain an
			 anabolic steroid that have been exempted by the Secretary:
NDC Number
(1)
			 Andro-Estro 90-4
			 ---------------------------------------------------------------------------------
			 0536-1605
(2) Androgyn L.A
			 -------------------------------------------------------------------------------------
			 0456-1005
(3) Component E-H in
			 Process Pellets ---------------------------------------------------------- Ivy
			 Labs Inc.
(4) Component E-H in
			 Process Granulation --------------------------------------------------- Ivy
			 Labs Inc
(5) Component TE-S in
			 process Granulation -------------------------------------------------- Ivy Labs
			 Inc
(6) Component TE-S in process
			 Pellets --------------------------------------------------------- Ivy Labs
			 Inc
(7) depANDROGYN
			 ---------------------------------------------------------------------------------
			 0456-1020
(8) Depo-Testadiol
			 ------------------------------------------------------------------------------------
			 0009-0253
(9) DEPO-T.E
			 -----------------------------------------------------------------------------------------
			 52765-257
(10) depTESTROGEN
			 -----------------------------------------------------------------------------
			 51698-257
(11) Duomone
			 ---------------------------------------------------------------------------------------
			 52047-360
(12) DUO-SPAN II
			 ---------------------------------------------------------------------------------
			 0684-0102
(13) DURATESTRIN
			 ------------------------------------------------------------------------------
			 43797-016
(14) Essian
			 --------------------------------------------------------------------------------------
			 Pharmaceutics
(15) Essian H.S
			 ---------------------------------------------------------------------------------
			 Pharmaceutics
(16) Esterified
			 Estrogens & Methyltestosterone, USP (0.625 mg/1.25mg) ----------------
			 Interpharm
(17) Esterified
			 Estrogens & Methyltestosterone, USP (1.25mg/2.5mg) --------------------
			 Interpharm
(18) Esterified
			 Estrogens & Methyltestosterone (0.625mg/1.25mg) Tablet -------------
			 ANDAPharm
(19) Esterified Estrogens
			 & Methyltestosterone (1.25mg/2.5mg) Tablet ----------------
			 ANDAPharm
(20) Estratest
			 -----------------------------------------------------------------------------------------
			 0032-1026
(21) Estratest HS
			 ------------------------------------------------------------------------------------
			 0032-1023
(22) Menogen
			 ----------------------------------------------------------------------------------------
			 59243-570
(23) Menogen HS
			 -----------------------------------------------------------------------------------
			 59243-560
(24) Methyltestosterone
			 & Esterified Estrogens (2.5mg/1.25Mg) --------------------------- Lannett
			 Co
(25) Methyltestosterone &
			 Esterified Estrogens (Half Strength) (1.25mg/0.625mg) ----- Lannett
			 Co
(26) PAN ESTRA TEST
			 ---------------------------------------------------------------------------
			 0525-0175
(27) Premarin with
			 Methyltestosterone ----------------------------------------------------------
			 0046-0879
(28) Premarin with
			 Methyltestosterone ----------------------------------------------------------
			 0046-0878
(29) Syntest D.S
			 -------------------------------------------------------------------------------------
			 66576-231
(30) Stntest H.S
			 --------------------------------------------------------------------------------------
			 66576-230
(31) Synovex H in process
			 bulk pellets ---------------------------------------------------- Syntex
			 Animal
(32) Synovex H in process
			 granulation ---------------------------------------------------- Syntex
			 Animal
(33) Synovex Plus in process
			 granulation ------------------------------------------------------ Fort
			 Dodge
(34) Synovex Plus in process
			 bulk pellets ------------------------------------------------------ Fort
			 Dodge
(35) TEST-ESTRO Cypionates
			 -------------------------------------------------------------------
			 0536-9470
(36) Testoderm with
			 Adhesive 4mg/d ------------------------------------------------------------
			 Alza Corp
(37) Testoderm 4mg/d
			 ----------------------------------------------------------------------------
			 17314-4608
(38) Testoderm 6mg/d
			 ----------------------------------------------------------------------------
			 17314-4609
(39) Testoderm with
			 Adhesive 6mg/d ----------------------------------------------------------
			 17314-2836
(40) Testoderm in
			 process film
			 -------------------------------------------------------------------- Alza
			 Corp
(41) Testoderm with Adhesive
			 in process film ------------------------------------------------- Alza
			 Corp
(42) Testosterone
			 Cypionate/Estradiol Cypionate injection -----------------------------------
			 54274-530
(43) Testosterone
			 Cypionate/Estradiol Cypionate injection -----------------------------------
			 0182-3069
(44) Testosterone Cyp 50
			 Estradiol Cyp 2 ------------------------------------------------------
			 0814-7737
(45) Testosterone
			 Cypionate/Estradiol Cypionate injection -----------------------------------
			 0364-6611
(46) Testosterone
			 Cypionate/Estradiol Cypionate injection -----------------------------------
			 0402-0257
(47) Testosterone
			 Enanthate/Estradiol Valerate injection --------------------------------------
			 0182-3073
(48) Testosterone
			 Enanthate/Estradiol Valerate injection --------------------------------------
			 0364-6618
(49) Testosterone
			 Enanthate/Estradiol Valerate injection --------------------------------------
			 0402-0360
(50) Testosterone
			 Ophthalmic Solution
			 ------------------------------------------------------------ Allergan
(51) Tilapia Sex Reversal Feed
			 (investigational ------------------------------------------------ Ranger,
			 Inc
(h) Veterinary
			 Anabolic Steroid Implant Products: Anabolic steroid products expressly intended
			 for administration through implants in cattle or other nonhuman species
			 exempted by the Secretary.
NDC/DIN
(1) Component
			 E-H
			 --------------------------------------------------------------------------------
			 021641-002
(2) Component E-H
			 -----------------------------------------------------------------------------------
			 01968327
(3) Component TE-S
			 -------------------------------------------------------------------------------
			 021641-004
(4) Component T-H
			 -------------------------------------------------------------------------------
			 0211641-006
(5) Component T-S
			 --------------------------------------------------------------------------------
			 0211641-005
(6) F-TO
			 ------------------------------------------------------------------------------------------------
			 00093351
(7) Finaplix-H
			 ------------------------------------------------------------------------------------
			 12799-807-10
(8) Finaplix-S
			 ------------------------------------------------------------------------------------
			 12799-807-07
(9) Heifer-old
			 ----------------------------------------------------------------------------------------
			 Boehringer
(10) Heifer-old
			 --------------------------------------------------------------------------------------
			 Ingelheim
(11) Heifer-old
			 ----------------------------------------------------------------------------------------
			 Ivy Lab.
(12) Implus-H
			 ----------------------------------------------------------------------------------
			 0009-0434-01
(13) Implus-H
			 --------------------------------------------------------------------------------------
			 06-0434-01
01968327
(14) Masculinizing Feed for Fish
			 (Invesitigational) ------------------------------------------
			 Rangen,Inc.
(15) Revalor-G
			 --------------------------------------------------------------------------------------
			 12799-811
(16) Revalor-H
			 --------------------------------------------------------------------------------------
			 12799-810
(17) Revalor-S
			 --------------------------------------------------------------------------------------
			 12799-809
(18) Synovex H
			 -------------------------------------------------------------------------------------
			 0856-3901
(19) Synovex H
			 -----------------------------------------------------------------------------------------
			 Syntex
(20) Synovex Plus
			 ----------------------------------------------------------------------------------
			 0856-3904
(21) Tilapia Sex Reversal
			 Feed (investigational) -------------------------------------------- Zeigier
			 Bros.
If veterinary products that are granted exempted status are
				subsequently distributed with the intent that they be used in humans, the
				distribution would be subject to the criminal sanctions of the CSA despite the
				drugs' exempted status.
(i)
Hallucinogenic substances:
(1) Dronabinol (synthetic) in sesame oil and
			 encapsulated in a soft gelatin capsule in a U.S. Food and Drug Administration
			 approved drug product ---------------------- 7369-(11-1987)
[Some other names for dronabinol: (6a R-trans)-6a,7,8,
				10a-tetrahydro-6, 6, 9-trimethyl-3-pentyl-6H-dibenzo [b,d] phyran-1-ol, or
				(-)-delta 9-(trans)-tetrahydrocannabinol]
SCHEDULE IV
(a) Schedule IV shall consist of the drugs
			 and other substances, by whatever official name, common or usual name, chemical
			 name or brand name designated, listed in this section. Each drug or substance
			 has been assigned the DEA Controlled Substances Code Number set forth opposite
			 it.
(b)
Narcotic
			 drugs:
Unless specifically excepted or unless listed in another
			 schedule, any material, compound, mixture, or preparation containing any of the
			 following narcotic drugs, or their salts calculated as the free anhydrous base
			 or alkaloid, in limited quantities as set forth below:
(1) Not more than 1 milligram of difenoxin
			 and not less than 25 micrograms of atropine sulfate per dosage unit
			 ----------------------------------------------------------------------
			 9167*
(2) Dextro propoxyphene
			 (alpha-(+)-4-dimethylamino- 1,2-diphenyl-3-methyl-2-propionoxybutane)
			 -------------------------------------------------------------------------
			 9278-(11-1987)
(c)
Depressants:
Unless specifically excepted or unless listed in
			 another schedule, any material, compound, mixture, or preparation which
			 contains any quantity of the following substances, including its salts,
			 isomers, and salts of isomers whenever the existence of such salts, isomers,
			 and salts of isomers is possible within the specific chemical designation:
(1) Alprazolam
			 -----------------------------------------------------------------------------------
			 2882-(6-1982)
(2) Barbital
			 -------------------------------------------------------------------------------------------------
			 2145*
(3) Bromazepam
			 ---------------------------------------------------------------------------------
			 2748-(1-1985)
(4) Camazepam
			 ----------------------------------------------------------------------------------
			 2749-(1-1985)
(5) Chloral betaine
			 -----------------------------------------------------------------------------------------
			 2460*
(6) Chloral hydrate
			 ----------------------------------------------------------------------------------------
			 2465*
(7) Chlordiazepoxide
			 -------------------------------------------------------------------------------------
			 2744*
(8) Clobazam
			 -------------------------------------------------------------------------------------
			 2751-(1-1985)
(9) Clonazepam
			 --------------------------------------------------------------------------------------------
			 2737*
(10) Clorazepate
			 -----------------------------------------------------------------------------------------
			 2768*
(11) Clotiazepam
			 ------------------------------------------------------------------------------
			 2752-(1-1985)
(12) Cloxazolam
			 -------------------------------------------------------------------------------
			 2753-(1-1985)
(13) Delorazepam
			 -----------------------------------------------------------------------------
			 2754-(1-1985)
(14) Diazepam
			 -------------------------------------------------------------------------------------------
			 2765*
(15) Dichloralphenazone
			 -------------------------------------------------------------------
			 2467-(10-2002)
(16) Estazolam
			 ---------------------------------------------------------------------------------
			 2756-(1-1985)
(17) Ethchlorvynol
			 --------------------------------------------------------------------------------------
			 2540*
(18) Ethinamate
			 ------------------------------------------------------------------------------------------
			 2545*
(19) Ethyl loflazepate
			 -------------------------------------------------------------------------
			 2758-(1-1985)
(20) Fludiazepam
			 ------------------------------------------------------------------------------
			 2759-(1-1985)
(21) Flunitrazepam
			 ----------------------------------------------------------------------------
			 2763-(1-1985)
(22) Flurazepam
			 -----------------------------------------------------------------------------------------
			 2767*
(23) Fospropofol
			 ------------------------------------------------------------------------------
			 2138-(11-2009)
(24) Halazepam
			 --------------------------------------------------------------------------------
			 2762-(6-1982)
(25) Haloxazolam
			 -----------------------------------------------------------------------------
			 2771-(1-1985)
(26) Ketazolam
			 --------------------------------------------------------------------------------
			 2772-(1-1985)
(27) Loprazolam
			 -------------------------------------------------------------------------------
			 2773-(1-1985)
(28) Lorazepam
			 -----------------------------------------------------------------------------------------
			 2885*
(29) Lormetazepam
			 ---------------------------------------------------------------------------
			 2774-(1-1985)
(30) Mebutamate
			 ----------------------------------------------------------------------------------------
			 2800*
(31) Medazepam
			 -------------------------------------------------------------------------------
			 2836-(1-1985)
(32) Meprobamate
			 ---------------------------------------------------------------------------------------
			 2820*
(33) Methohexital
			 ---------------------------------------------------------------------------------------
			 2264*
(34) Methylphenobarbital
			 (mephorbarbital) ---------------------------------------------------------
			 2250*
(35) Midazolam
			 --------------------------------------------------------------------------------
			 2884-(1-1985)
(36) Nimetazepam
			 -----------------------------------------------------------------------------
			 2837-(1-1985)
(37) Nitrazepam
			 -------------------------------------------------------------------------------
			 2834-(1-1985)
(38) Nordiazepam
			 -----------------------------------------------------------------------------
			 2838-(1-1985)
(39) Oxazepam
			 -------------------------------------------------------------------------------------------
			 2835*
(40) Oxazolam
			 -------------------------------------------------------------------------------------------
			 2839*
(41) Paraldehyde
			 -----------------------------------------------------------------------------------------
			 2585*
(42) Petrichloral
			 -----------------------------------------------------------------------------------------
			 2591*
(43) Phenobarbital
			 ---------------------------------------------------------------------------------------
			 2285*
(44) Pinazepam
			 --------------------------------------------------------------------------------
			 2883-(1-1985)
(45) Prazepam
			 --------------------------------------------------------------------------------------------
			 2764*
(46) Quazepam
			 --------------------------------------------------------------------------------
			 2881-(11-1986)
(47) Temazepam
			 -------------------------------------------------------------------------------
			 2925-(9-1981)
(48) Tetrazepam
			 -------------------------------------------------------------------------------
			 2886-(1-1985)
(49) Triazolam
			 ---------------------------------------------------------------------------------
			 2887-(7-1983)
(50) Zaleplon
			 -----------------------------------------------------------------------------------
			 2781-(9-1999)
(51) Zolpidem
			 --------------------------------------------------------------------------------
			 2783-(12-1993)
(52) Zopiclone
			 ----------------------------------------------------------------------------------
			 2784-(1-2006)
(53) Alfaxalone
			 ---------------------------------------------------------------------------------
			 2731-(2-2014)
(54) Carisoprodol
			 ------------------------------------------------------------------------------
			 8192-(4-1997)
(55) Tramadol
			 ----------------------------------------------------------------------------------
			 9752-(8-2007)
(56) Suvorexant
			 --------------------------------------------------------------------------------
			 2223-(8-2014)
(57) Brexanolone
			 ------------------------------------------------------------------------------
			 2400-(4-2021)
(58) Lemborexant
			 -----------------------------------------------------------------------------
			 2245-(4-2021)
(59) Remimazolam
			 ----------------------------------------------------------------------------
			 2846-(5-2022)
(60) Daridorexant
			 ------------------------------------------------------------------------------------------
			 2410
(d)
Stimulants:
Unless specifically excepted or unless listed in
			 another schedule, any material, compound, mixture, or preparation which
			 contains any quantity of the following substances having a stimulant effect on
			 the central nervous system, including its salts, isomers (whether optical,
			 position, or geometric), and salts of such isomers whenever the existence of
			 such salts, isomers, and salts of isomers is possible within the specific
			 chemical designation:
(1) Cathine
			 ((+)-Norpseudeophedrine
			 ---------------------------------------------------------
			 1230-(3-1988)
(2) Diethylpropion
			 -----------------------------------------------------------------------------------------
			 1610*
(3) Fencamfamin
			 --------------------------------------------------------------------------------
			 1760-(3-1988)
(4) Fenproporex
			 ----------------------------------------------------------------------------------
			 1575-(3-1988)
(5) Lorcaserin
			 ------------------------------------------------------------------------------------
			 1625-(6-2013)
(6) Mazindol
			 -------------------------------------------------------------------------------------
			 1605-(6-1982)
(7) Mefenorex
			 ------------------------------------------------------------------------------------
			 1580-(3-1988)
(8) Modafinil
			 --------------------------------------------------------------------------------------
			 1680-(1-1999)
(9) Pemoline
			 (including organometallic complexes and chelates thereof)
			 ------------------------- 1530*
(10) Phentermine
			 ----------------------------------------------------------------------------------------
			 1640*
(11) Pipradrol
			 ----------------------------------------------------------------------------------
			 1750-(9-1981)
(12)
			 Serdexmethylphenidate
			 -----------------------------------------------------------------------------
			 1729
(13) Sibutramine
			 -------------------------------------------------------------------------------
			 1675-(2-1998)
(14) Solriamfetol
			 ------------------------------------------------------------------------------
			 1650-(4-2021)
(15) SPA
			 ((-)-1-dimethylamino-1,2,diphenylethane) -------------------------------------
			 1635-(9-1981)
(e)
Other substances:
Unless specifically excepted or unless listed in
			 another schedule, any material, compound, mixture, or preparation which
			 contains any quantity of the following substances, including its salts; isomers
			 whether optical, position, or geometric), and salts of such isomers, whenever
			 the existence of such salts, isomers, and salts of isomers is possible:
(1) Pentazocine
			 ----------------------------------------------------------------------------------
			 9709-(4-1979)
(2) Butorphanol
			 ----------------------------------------------------------------------------------
			 9720-(4-1997)
(3) Nalbuphine
			 ------------------------------------------------------------------------------------------
			 (4-1997)
(4) Eluxadoline
			 ----------------------------------------------------------------------------------
			 9725-(4-2017)
SCHEDULE V
(a) Schedule V shall consist of the drugs and
			 other substances by whatever official name, common or usual name, chemical
			 name, or brand name designated, listed in this section.
(b)
Narcotic Drugs:
Unless
			 specifically excepted or unless listed in another schedule, any material,
			 compound, mixture or preparation containing any of the following narcotic drugs
			 and their salts, as set forth below.
Reserved
(c)
Narcotic drugs containing
			 nonnarcotic active medicinal ingredients.
Any compound, mixture, or
			 preparation containing any of the following limited quantities of narcotic
			 drugs or salts thereof, which shall include one or more nonnarcotic active
			 medicinal ingredients in sufficient proportion to confer upon the compound,
			 mixture, or preparation valuable medicinal qualities other than those possessed
			 by the narcotic drug alone:
(1) Not more than
			 200 milligrams of codeine per 100 milliliters or per 100 grams.
			 -------------------- *
(2) Not more
			 than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams.
			 ----------------------------------------------------------------------------------------------------------
			 *
(3) Not more than 100 milligrams
			 of ethylmorphine per 100 milliliters or per 100 grams.
			 ----------------------------------------------------------------------------------------------------------
			 *
(4) Not more than 2.5 milligrams
			 of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage
			 unit. ------------------------------------------------------------------------
			 *
(5) Not more than 100 milligrams
			 of opium per 100 milliliters or per 100 grams. ----------------------
			 *
(6) Not more than 0.5 milligrams
			 of difenoxin and not less than 25 micrograms of atropine sulfate per dosage
			 unit.
			 ---------------------------------------------------------------------------
			 *
(d)
Stimulants:
unless specifically excepted or unless listed in
			 another schedule, any material, compound, mixture, or preparation which
			 contains any quantity of the following substances having stimulant effect on
			 the central nervous system, including its salts, isomers and salts of isomers:
(1) Pyrovalerone
			 ---------------------------------------------------------------------------------
			 1485-(3-1988)
(2) Ephedrine:a
			 -{-(Methylamino)ethyl}benzene-methanol; -------------------------------------
			 (10-1995)
a-{-(methylamino) ethyl}benzyl alcohol;
				2-methylamino-1-phenyl-1-propanol; 1-phenyl-1-hydroxy-2-methylaminopropane;
				1-phenyl-2-methylaminopropanol; a - hydroxy-b-methylaminopropylbenzene; a
				product which occurs in the Chinese herb Ma Huang (Ephedra vulgaris, Ephedra
				sinica Stapf., Ephedra equisetina Bunge, Gnetaceae) in several other Ephedra
				spp.
(3)
			 Phenylpropanolamine
			 ------------------------------------------------------------------------------
			 (7-2005)
(4) Pseudoephedrine
			 -----------------------------------------------------------------------------------
			 (7-2005)
Pursuant to Ark. Code Ann. §
											5-64-212 as amended in 2005, this
				Schedule V classification shall NOT apply to any ephedrine,
				phenylpropanolamine, or pseudoephedrine in liquid, liquid capsule, or liquid
				gel capsule form. However, sales limits mandated by statute shall apply to all
				products with ephedrine, phenylpropanolamine, or pseudoephedrine as a listed
				ingredient regardless of the dosage form.
(e)
Depressants:
Unless
			 specifically exempted or excluded or unless listed in another schedule, any
			 material, compound, mixture, or preparation which contains any quantity of the
			 following substances having a depressant effect on the central nervous system,
			 including its salts, isomers, and salts of isomers:
(1) Pregabalin
			 [(S)-3-(aminomethyl)-5-methylhexanoic acid ------------------------------
			 2782-(1-2006)
(2) Lacosamide
			 ----------------------------------------------------------------------------------
			 2746-(5-2009)
(3) Brivaracetam
			 ---------------------------------------------------------------------------------
			 2710-(4-2017)
(4) Lasmiditan
			 -----------------------------------------------------------------------------------
			 2790-(4-2021)
(5) Cenobamate
			 ----------------------------------------------------------------------------------
			 2720-(4-2021)
(6) Ganaxolone
			 -----------------------------------------------------------------------------------------------
			 2401
(f)
Other
			 substances:
(1) None.
SCHEDULE VI ****
(a) In addition to any substance placed in
			 Schedule VI by the Secretary of the Department of Health under §
									5-64-214, any material, compound,
			 mixture, or preparation, whether produced directly or indirectly from a
			 substance of vegetable origin or independently by means of chemical synthesis,
			 or by a combination of extraction and chemical synthesis, that contains any
			 quantity of the following substances, or that contains any of their salts,
			 isomers, and salts of isomers when the existence of the salts, isomers, and
			 salts of isomers is possible within the specific chemical designation, is
			 included in Schedule VI:
(1) Marijuana
			 ----------------------------------------------------------------------------------------------------
			 **
(2) Tetrahydrocannabinols,
			 unless the tetrahydrocannabinol is: ------------------------------------------
			 **
(i) Contained in hemp-derived cannabidiol;
			 --------------------------------------------------- (6-2020)
(ii) Not more than three-tenths of one
			 percent (0.3%) of delta-9 tetrahydrocannabinol in the hemp-derived cannabidiol
			 on a dry weight basis as verified by a nationally accredited laboratory for
			 quality, purity and accuracy standards; and
			 ---------------------------------------------------------- (6-2020) ***
(iii) Not approved by the United
			 States Food and Drug Administration for marketing as a medication;
			 ----------------------------------------------------------------
			 (6-2020)
(3) A synthetic
			 equivalent of:
(i) The substance contained in
			 the Cannabis plant; or ----------------------------------------------
			 **
(ii) The substance contained in
			 the resinous extractives of the genus Cannabis; ---------------- **
(4) Salvia divinorum or Salvinorin
			 A, which includes all parts of the plant presently classified botanically as
			 Salvia divinorum, whether growing or not, the seeds of the plant, any extract
			 from any part of the plant, and every compound, manufacture, derivative,
			 mixture, or preparation of the plant, its seeds, or its extracts, including
			 salts, isomers, and salts of isomers when the existence of the salts, isomers,
			 and salts of isomers is possible within the specific chemical designation;
			 --------------------------------------------------------------------------------------------------
			 **
(5) Synthetic substances,
			 derivatives, or their isomers in the chemical structural classes described
			 below in subdivisions (a)(5)(i)-(a)(5)(x) of this section and also specific
			 unclassified substances in subdivision (a)(5)(xi) of this section. Compounds of
			 the structures described in this subdivision (a)(5), regardless of numerical
			 designation of atomic positions, are included in this subdivision (a)(5). The
			 synthetic substances, derivatives, or their isomers included in this
			 subdivision (a)(5) are:
(i)
			 Tetrahydrocannabinols:
(A)
			 Tetrahydrocannabinols, including without limitation the following:
			 ----------------------- **
a) Delta-1 cis or
			 trans tetrahydrocannabinol [other name(s): Delta-9 cis or trans
			 tetrahydrocannabinol], and its optical isomers;
			 ------------------------------------ **
b) Delta-6 cis or trans tetrahydrocannabinol
			 [other name(s): Delta-8 cis or trans tetrahydrocannabinol], and its optical
			 isomers; ------------------------------------- **
c) Delta- 3,4 cis or trans
			 tetrahydrocannabinol [other name(s): Delta-6a,10a cis or trans
			 tetrahydrocannabinol], and its optical isomers; --------------------
			 **
d) Delta-10 cis or trans
			 tetrahydrocannabinol, and its optical isomers; ------------------ ***
e) Delta-8 tetrahydrocannabinol acetate
			 ester; ---------------------------------------------- ***
f) Delta-9 tetrahydrocannabinol acetate
			 ester; ---------------------------------------------- ***
g) Delta-6a,10a, tetrahydrocannabinol acetate
			 ester; ---------------------------------------- ***
h) Delta-10 tetrahydrocannabinol acetate
			 ester; and, ---------------------------------------- ***
i) A product derived from industrial hemp
			 that was produced as a result of a synthetic chemical process that converted
			 the industrial hemp or a substance contained in industrial hemp into Delta-8,
			 Delta-9, Delta 6a,10a, or Delta-10 tetrahydrocannabinol including their
			 respective acetate esters.
			 ---------------------------------------------------------------------------------
			 ***
(B) Dronabinol in
			 sesame oil and encapsulated in a soft gelatin capsule in a drug product
			 approved by the United States Food and Drug Administration is not a
			 tetrahydrocannabinol under this subdivision (a) (5) (i);
			 --------------------------------------------------------------------------------------------
			 **
(ii)
			 Naphthoylindoles, or any compound structurally derived from
			 3-(1-naphthoyl)indole or 1H-indol-3-yl-(1-naphthyl)methane by substitution at
			 the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl,
			 cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or
			 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole
			 ring to any extent and whether or not substituted in the naphthyl ring to any
			 extent, including without limitation the following:
			 ----------------------------- **
(A) JWH-007,
			 or 1-pentyl-2-methyl-3-(1-naphthoyl)indole;
			 ------------------------------------- **
(B) JWH-015, or
			 1-Propyl-2-methyl-3-(1-naphthoyl)indole; ------------------------------------
			 **
(C) JWH-018, or
			 1-Propyl-3-(1-naphthoyl)indole;
			 --------------------------------------------------
(D) JWH-019, or
			 1-Hexyl-3-(1-naphthoyl)indole; ------------------------------------------------
			 **
(E) JWH-073, or
			 1-Butyl-3-(1-naphthoyl)indole; ------------------------------------------------
			 **
(F) JWH-081, or
			 1-Pentyl-3-(4-methoxy-1-naphthoyl)indole; ----------------------------------
			 **
(G) JWH-098, or
			 1-pentyl-2-methyl-3-(4-methoxy-1-naphthoyl)indole; -----------------------
			 **
(H) JWH-122, or
			 1-Pentyl-3-(4-methyl-1-naphthoyl)indole; -------------------------------------
			 **
(I) JWH-164, or
			 1-pentyl-3-(7-methoxy-1-naphthoyl)indole; -----------------------------------
			 **
(J) JWH-200, or
			 1-[2-(4-morpholiny)ethyl]-3-(1-naphthoyl) indole; --------------------------
			 **
(K) JWH-210, or
			 1-Pentyl-3-(4-ethyl-1-naphthoyl)indole; ---------------------------------------
			 **
(L) JWH-398, or
			 1-Pentyl-3-(4-chloro-1-naphthoyl)indole; -------------------------------------
			 **
(M) AM-2201, or
			 1-(5-fluoropentyl)-3-(1-naphthoyl)indole; ------------------------------
			 **
(N) MAM2201, or
			 (1-(5-fluoropentyl)-1H-indol-3-yl)(4-methyl-1-naphthalenyl)-methanone;
			 -----------------------------------------------------------------------
			 **
(O) EAM2201, or
			 (1-(5-fluoropentyl)-1H-indol-3-yl)(4-ethyl-1-naphthalenyl)-methanone; and
			 ------------------------------------------------------------------------------------
			 **
(P) THJ-2201, or
			 [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone;
			 -----------------------------------------------------------------------
			 7024-(7-2019)
(iii)
			 Naphthylmethylindoles, or any compound structurally derived from an
			 H-indol-3-yl-(1-naphthyl) methane by substitution at the nitrogen atom of the
			 indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
			 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or
			 not further substituted in the indole ring to any extent and whether or not
			 substituted in the naphthyl ring to any extent, including without limitation
			 the following: ---------------------------------------------------------------
			 **
(A) JWH-175, or
			 1-Pentyl-1H-indol-3-yl-(1-naphthyl)methane; and ----------------------------
			 **
(B) JWH-184, or
			 1-Pentyl-1H-3-yl-(4-methyl-1-naphthyl)methane; ---------------------------
			 **
(iv)
			 Naphthoylpyrroles, or any compound structurally derived from
			 3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring
			 by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
			 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or
			 not further substituted in the pyrrole ring to any extent and whether or not
			 substituted in the naphthyl ring to any extent, including without limitation
			 JWH-307, or (5-(2-fluorophenyl)-1-pentylpyrrol-3-yl)-naphthalen-1-ylmethanone;
			 --------------------------------------------------------------------------------------
			 **
(v) Naphthylmethylindenes, or
			 any compound structurally derived from 1-(1-napthylmethyl)indene with
			 substitution at the 3-position of the indene ring by an alkyl, haloalkyl,
			 alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl,
			 or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the
			 indene ring to any extent and whether or not substituted in the naphthyl ring
			 to any extent, including without limitation JWH-176, or
			 E-1-[1-(1-Naphthalenylmethylene)-1H-inden-3-yl]pentane; ---------------
			 **
(vi) Phenylacetylindoles, or any
			 compound structurally derived from 3-phenylacetylindole by substitution at the
			 nitrogen atom of the indole ring with alkyl, haloalkyl, alkenyl,
			 cycloalkylmethyl,cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or
			 2-(4-morpholinyl)ethyl group whether or not further substituted in the indole
			 ring to any extent and whether or not substituted in the phenyl ring to any
			 extent, including without limitation the following:
			 --------------------------------------------------------------------------------------
			 **
(A) JWH-201, or
			 2-(4-methoxyphenyl)-1-(1-pentylindol-3-yl)ethanone; -----------------------
			 **
(B) JWH-203, or
			 1-Pentyl-3-(2-chlorophenylacetyl)indole; -------------------------------------
			 **
(C) JWH-250, or
			 1-Pentyl-3-(2-methoxyphenylacetyl)indole; ----------------------------------
			 **
(D) JWH-251, or
			 1-Pentyl-3-(2-methylphenylacetyl)indole; and --------------------------------
			 **
(E) RCS-8, or
			 1-(2-cyclohexylethyl)-3-(2- methoxyphenylacetyl)indole; ---------------------
			 **
(vii)
			 Cyclohexylphenols, or any compound structurally derived from
			 2-(3-hydroxycyclohexyl)phenol by substitution at the 5-position of the phenolic
			 ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
			 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or
			 not substituted in the cyclohexyl ring to any extent, including without
			 limitation the following:
			 ------------------------------------------------------------------------- **
(A) CP 47,497
			 5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol;
			 ----------------------------------------------------------------------------------------------
			 **
(B) Cannabicyclohexanol or CP
			 47,497 C8 homologue, or
			 5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol; and
			 ------------------------------ **
(C) CP 55,940, or
			 5-(1,1-dimethylheptyl)-2-[(1R,2R)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]-phenol;
			 ------------------------------------------------------------ **
(viii) Benzoylindoles, or any
			 compound structurally derived from a 3-(benzoyl)indole structure with
			 substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl,
			 alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or
			 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole
			 ring to any extent and whether or not substituted in the phenyl ring to any
			 extent, including without limitation the following:
			 --------------------------------------------------------------- **
(A) AM-694, or
			 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole; -----------------------------------
			 **
(B) RCS-4, or
			 1-Pentyl-3-(4-methoxybenzoyl)indole;
			 -------------------------------------------- **
(C) WIN-48,098 or Pravadoline, or
			 (4-Methoxyphenyl)-[2-methyl-1-(2-(4-morpholinyl)ethyl)indol-3-y]methanone;
			 ----------------------------------------------------- **
(D) AM-2233, or
			 1-[(N-methylpiperidin-2-yl)methyl]-3-(2-iodobenzoyl)indole; and
			 --------------------------------------------------------------------------
			 **
(E) RCS-4 (C4 homologue) or
			 (4-methoxyphenyl)(1-butyl-1H-indol-3-yl)-methanone;
			 -----------------------------------------------------------------------------------------
			 **
(ix)
			 Adamantoylindoles, or Adamantoylindazoles, including Adamantyl Carboxamide
			 Indoles and Adamantyl Carboxamide Indazoles, or any compound structurally
			 derived from 3-(1-adamantoyl) indole, 3-(1-adamantoyl) indazole, or
			 3-(2-adamantoyl)indole by substitution at a nitrogen atom of the indole or
			 indazole ring with alkyl, haloalkyl, alkenyl, cyanoalkyl, hydroxyalkyl,
			 cycloalkylmethyl,cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or
			 2-(4-morpholinyl)ethyl, whether or not further substituted in the indole or
			 indazole ring to any extent and whether or not substituted in the adamantly
			 ring to any extent, including without limitation the following:
			 ------------------------------------------------------------------------- **
(A) AM-1248, or
			 1-adamantyl-[1-[(1-methylpiperidin-2-yl)methyl]indol-3-yl]methanone;
			 -------------------------------------------------------------------------------------
			 **
(B) AB-001, or
			 1-adamantyl-(1-pentylindol-3-yl)methanone; -----------------------------------
			 **
(C) JWH-018 adamantyl
			 carboxamide, or 1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indole-3-carboxamide
			 [other name(s): 2NE1, moved in Schedule VI in 2020]
			 -----------------------------------------------------------------------------------------
			 **
(D) AKB-48, or
			 N-(1-adamantyl)-pentyl-1H-indazole-3-carboxamide; -----------------------
			 **
(E) 5F-AKB-48, or
			 N-((3s,5s,7s)-adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide
			 ------------------------------------------------------------------
			 7049**
(F) STS-135, or
			 N-(1-adamantyl)-1-(5-fluoropentyl)indole-3-carboxamide; -----------------
			 **
(x)
			 Tetramethylcyclopropylcarbonylindoles or any compound structurally derived from
			 3-(2,2,3,3-tetramethylcyclopropylcarbonyl) indole by substitution at the
			 nitrogen atom of the indole ring with alkyl,haloalkyl, alkenyl, cyanoalkyl,
			 hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)methyl
			 or 2-(4-morpholinyl)ethyl, whether or not further substituted in the indole
			 ring to any extent, including without limitation the following:
			 ------------------------------------------------------------------------- **
(A) UR-144, or
			 (1-pentylindol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone;
			 ------------------------------------------------------------ **
(B) XLR-11, or
			 [1-(5-fluoropentyl)-1H-indol-3-yl]-(2,2,3,3-tetramethylcyclopropyl)methanone;
			 ------------------------------------------------------------ **
(C) A-796,260, or
			 [1-(2-morpholin-4-yl-ethyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone;
			 ------------------------------------------------------------ **
(D) 5-Chloro-UR-144, or
			 ([-(5-chloropentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone;
			 ------------------------------------------------------------ **
(E) 5-Bromo-UR-144, or
			 [1-(5-bromopentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone; and
			 ------------------------------------------------------- **
(F) A-834,735, or
			 1-(tetrahydropyran-4-ylmethyl)-1H-indol-3-yl]-(2,2,3,3-tetramethylcyclopropyl)methanone;
			 ------------------------------------------------------------ **
(xi) Unclassified Synthetic
			 Cannabinoids, including without limitation the following:
			 ------------------------------------------------------------------------------------------
			 **
(A) CP 50556-1 hydrochloride, or
			 [(6S,6aR,9R,10aR)-9-hydroxy-6-methyl-3-[(2R)-5-phenylpentan-2-yl]oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1-yl]
			 Acetate; -------------------------------------------------------- **
(B) HU-210, or
			 (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;
			 -------------------------- **
(C)
			 HU-211, or
			 Dexanabinol,(6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;
			 ---------------------- **
(D)
			 Dimethylheptylpyran or DMHP;
			 --------------------------------------------------------------- **
(E) WIN55,212-2, or
			 2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl-1-naphthalenylmethanone;
			 -------------------------------------------------------------------------
			 **
(F) URB597, or
			 [3-(3-carbamoylphenyl)phenyl] N-Cyclohexylcarbamate; -------------------
			 **
(G) URB754, or
			 6-methyl-2-[(4-methylphenyl)amino]-1-benzoxazin-4-one; -----------------
			 **
(H) CB-13, or
			 1-naphthalenyl[4-(pentyloxy)-1 naphthalenyl]-methanone; -------------------- **
a) URB602, or cyclohexyl
			 N-(3-phenylphenyl)carbamate; --------------------------------- **
(I) PB-22, or quinolin-8-yl
			 1-(5-pentyl)-1H-indole-3-carboxylate; ---------------------------- **
(J) 5F-PB-22, or quinolin-8-yl
			 1-(5-fluoropentyl)-1H-indole-3-carboxylate; ---------------- **
(K) BB-22, or quinolin-8-yl
			 1-(cyclohexylmethyl)-1H-indole-3-carboxylate; --------------- **
(L) NNEI (MN-24), or
			 N-1-naphthalenyl-1-pentyl-1H-indole-3-carboxamide; -------------- **
(M) 5F-NNEI, or
			 1-(5-fluoropentyl)-N-(naphthalene-1-yl)-1H-indole-3-carboxamide;
			 -------------------------------------------------------------------------------------
			 **
(N) 5-Fluoro-AMB, or
			 n-[[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl]-L-valine methyl ester
			 -----------------------------------------------------------------
			 7033-(9-2018)
(O) MMB-CHMICA,or
			 methyl-(1-cyclohexylmethyl)-1H-indole-3-carbonyl)-L-valinate
			 ----------------------------------------------------------------------------
			 7044-(9-2018)
(P) 5-Fluoro-ADB, or
			 methyl 2-(1-(5-fluoropentyl)-1H- indazole-3-carboxamido)-3,3-dimethylbutanoate;
			 ----------------------------------------- 7034-(11-2018)
(Q) 5-Fluoro-MDMB-PICA, or methyl
			 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate
			 ------------------------------------------- 7041-(11-2018)
(R) MDMB-CHMICA, or methyl
			 2-(1-(cyclohexylmethyl)-1H- indole-3-carboxamido)-3,3-dimethylbutanoate;
			 ------------------------------------------ 7042-(11-2018)
(S) FUB-AMB, or methyl
			 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate;
			 ---------------------------------------------- 7021-(11-2018)
(T) MDMB-FUBINACA, or methyl
			 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate;
			 ----------------------------------------- 7020-(11-2018)
(U) AB-PINACA, or
			 N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-caroboxamide;
			 ---------------------------------------------------------
			 7023-(7-2019)
(V) AB-CHMINACA, or
			 N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide;
			 ------------------------------ 7031-(7-2019)
(W) MAB-CHMINACA, or
			 N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide;-
			 - ------------------------------- (11-2014)
(X) AB-FUBINACA, or
			 N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide;-
			 - ------------------------------------------- (9-2018)
(Y) ADB-PINACA, or
			 N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide;
			 --------------------------------------------------------------
			 (9-2018)
(Z) 5F-CUMYL-PINACA, or
			 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide
			 ------------------------------------------------------- 7083-(6-2020)
(AA) ADB-FUBINACA, or
			 N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide
			 ------------------------------------ 7010-(4-2021)
(BB) 4-Fluoro-MDMB-BUTINACA, or
			 methyl(S)-2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate;
			 --------------------------- 7043-(4-2021)
(CC) 5F-AB-PINACA, or
			 N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide
			 ------------------------------------ 7025-(5-2022)
(DD) 4-CN-CUMYL-BUTINACA, or
			 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide
			 --------------------------------------------- 7089 -(5-2022)
(EE) 5F-CUMYL-P7AICA, or
			 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide
			 ------------------------------------ 7085-(5-2022)
(FF) NM2201, or Naphthalen-1-yl
			 1-(5-fluoropentyl)-1H-indole-3-carboxylate
			 ------------------------------------------------------------------------
			 7221-(5-2022)
(GG) 5F-EDMB-PINACA,
			 or Ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate
			 ----------------------------------------------------- 7036
(HH) FUB-144, or
			 (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone;
			 ----------------------------------------------------- 7014
(II) FUB-AKB48, or
			 N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide;
			 ----------------------------------------------------------------------------------
			 7047
(JJ) MDMB-4en-PINACA, or
			 Methyl
			 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido)butanoate;
(KK) CH-PIATA, or
			 N-cyclohexyl-2-(1-pentylindol-3-yl)acetamide.
(6) A synthetic substance, derivative, or its
			 isomers with:
(i) Similar chemical structure
			 to any substance described in subdivisions (a)(1)-(a)(5) of this section; or
			 ---------------------------------------------------------------------------
			 **
(ii) Similar pharmacological
			 effects to any substance described in subdivisions (a)(1)-(a)(5) of this
			 section. ----------------------------------------------------------------------
			 **
(b)
			 However, except as provided under subsection (c) of this section, the Secretary
			 shall not delete a controlled substance listed in this section from Schedule
			 VI.
(c) A prescription drug
			 approved by the United States Food and Drug Administration under
			 21 U.S.C. §
										355 is excluded from Schedule VI unless the
			 secretary objects under §
									5-64-201.
*-Scheduled before April, 1979.
**-Schedule VI is revised to conform to Act 329 of 2013.
*** - Schedule VI is revised further to conform to Act 629 of
				2023. Each substance added to the Controlled Substances List pursuant to Act
				629 of 2023 shall have the following effective dates:
(a) For persons who are under twenty-one (21)
			 years of age, the effective date shall be the effective date of Act 629 of
			 2023; and,
(b) For persons who are
			 twenty-one (21) years of age or older, the effective date shall be August 1,
			 2023.
**** Pursuant to ongoing litigation, and a preliminary
				injunction against enforcing Act 629 of 2023, the changes made to the List of
				Controlled Substances pursuant to Act 629 of 2023 are not enforceable until a
				final order issued in the matter, Bio Gen, LLC, et al. v. Sarah Huckabee
				Sanders, et al., Case No. 4:23-CV-00718-BRW, Central Division, Eastern District
				of Arkansas, United States District Court.